Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

A sequencing-free blood test on a chip can classify lung cancer using chemical fingerprints in cell-free DNA. More...
11 Aug 2026
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

A new test that analyzes intact circulating tumor cells aims to offer a clinically superior alternative to standard fragment-based blood tests. More...
11 Aug 2026
Image: The platform analyzes cell-free DNA in blood, searching for minute amounts of tumor-derived fragments among background DNA (Image Credit: Adobe Stock)

Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

A blood-based AI platform triages suspected lymphoma for faster biopsy, offering strong detection and differentiation from benign causes. More...
10 Aug 2026
Image Credit: Adobe Stock

Liquid Biopsy Assay Enriches Tumor DNA for Early Detection and Monitoring

A new liquid biopsy method isolates over 99% pure ctDNA from plasma, enabling multi-cancer early detection and MRD surveillance. More...
10 Aug 2026
Image: The adverse effects of abnormalities in SLF2 and SMC5. (Image Credit: KyotoU / Sho Shibata)

New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome

Researchers identify inherited genetic variants that define a new bone marrow failure disorder and blood cancer risk. More...
10 Aug 2026
Image: The Co-Dx PCR platform combines real-time PCR quality with a lower-cost instrument and consumable model to facilitate deployment near the patient (Photo courtesy of Co-Diagnostics, Inc.)

Point-of-Care Multiplex PCR Test Submitted to FDA for Flu A/B and RSV Detection

Co-Diagnostics has submitted a Dual 510(k) with concurrent CLIA Waiver to the FDA for Flu A/B & RSV multiplex test. More...
10 Aug 2026
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

A newly cleared digital pathology system expands interoperability and cloud support for primary diagnosis. More...
10 Aug 2026
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
HPV Molecular Test
BD Onclarity HPV Assay
Copyright © 2000-2026 Globetech Media. All rights reserved.